
This was the first study to compare clinical outcomes in carbapenemase-producing (CP-CRE) and non–carbapenemase-producing (nCP-CRE) infections.
Patel is a PGY-2 ID pharmacy resident at Beth Israel Deaconess Medical Center in Boston, Massachusetts.

This was the first study to compare clinical outcomes in carbapenemase-producing (CP-CRE) and non–carbapenemase-producing (nCP-CRE) infections.

If resources and funds were unlimited, what would the ideal stewardship program look like?

Published: December 10th 2019 | Updated: